Brca
Brca - most related articles:
-
Women with BRCA mutation most likely to undergo mastectomy - 5.5
-
BRCA mutation increases breast cancer risk in opposite breast - 4.1
-
AMP joins ACLU to challenge BRCA gene patents - 3.3
-
New class of cancer drugs could work in colon cancers with genetic mutation - 2.2
-
Genetic variants may affect risk of breast cancer - 2.2
Brca articles
New class of cancer drugs could work in colon cancers with genetic mutationA class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.
New risk factor for developing breast cancerAn Australian research team from the Peter MacCallum Cancer Centre, the University of Melbourne and the University of Queensland has identified a new risk factor for developing breast cancer. This has been published online in the journal Cancer Prevention Research.
Genetic variants may affect risk of breast cancerAn international study led by researchers at Memorial Sloan-Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing breast cancer.
Preventive surgeries better in breast or ovarian cancer patientsA long-term study of women with a genetic predisposition for breast or ovarian cancer showed that those who elected major preventive surgeries had a significantly reduced risk of those cancers.
Preventive cancer surgeries save women's livesA new study underscores the importance for women with a family history of breast or ovarian cancer to get genetic counseling and testing for the BRCA1 and BRCA2 genes that make them more likely to develop lethal breast or ovarian cancer, says a Northwestern Medicine oncologist.
BRCA mutation increases breast cancer risk in opposite breastWomen with breast cancer before age 55 who carry an inherited mutation in the breast cancer susceptibility genes BRCA1 or BRCA2 are four times more likely to develop cancer in the breast opposite, or contralateral, to their initial tumor as compared to breast cancer patients without these genetic defects.
Isolated DNA Claims are Not Patentable, USA federal judge on Monday struck down patents on two genes -- BRCA1 and BRCA2 -- linked to breast and ovarian cancer. Shares of Myriad Genetics (MYGN.O) fell as much as 7 percent, a day after the ruling.
MRI detects breast cancer at earlier stageMagnetic resonance imaging (MRI) coupled with mammography detects almost all cancers at an early stage, thereby reducing the incidence of advanced stage breast cancer in high-risk women.
Breast cells responsible for breast cancersBreast cells called luminal progenitor cells are likely to be responsible for breast cancers that develop in women carrying mutations in the gene BRCA1, revealed by researchers.
AMP joins ACLU to challenge BRCA gene patentsThe Association for Molecular Pathology (AMP) announced that it is working with the American Civil Liberties Union (ACLU) and the Public Patent Foundation to bring a lawsuit charging that patents on two human genes associated with breast and ovarian cancer are unconstitutional and should be invalidated.
Women with BRCA mutation most likely to undergo mastectomyWomen at increased risk for breast cancer because of the genetic BRCA mutations are more likely to think a prophylactic mastectomy is the best way to reduce their risk for the disease, compared to other women who are at high risk, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Breast cancer gene mutation common in Hispanic, young black womenA genetic mutation already known to be more common in Ashkenazi Jewish breast cancer patients is also prevalent in Hispanic and young African-American women with breast cancer, according to one of the largest, multiracial studies of the mutation to date.
12 Brca articles listed above.
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.